INCYTE CORP (INCY)
NASDAQ • Healthcare
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About INCYTE CORP
Incyte Corporation develops and markets prescription therapies in biotechnology, with revenue of $5.1 billion in FY2025. Listed on the NASDAQ as INCY, the company combines commercial oncology and hematology drugs with a clinical pipeline and global marketing operations built around therapies it develops itself.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
INCYTE CORP's Technical Indicators Summary
INCY is positioned above its short-, medium- and long-term moving averages, reflecting broad bullish participation, and momentum indicators are largely constructive with a high CCI and positive momentum while RSI sits in a bullish range. Trend strength is moderate with ADX near 21, and volatility is reasonable with an ATR around $3.5. A notable caveat is a negative OBV reading despite price strength, suggesting some distribution beneath the surface, while the pivot sits below current price. Technical takeaway: broad moving-average alignment and momentum justify the strong-buy view, tempered by softer volume internals.
| Indicator | Value |
|---|---|
RSI (14) | 63.80 |
Stochastic %K (14, 3, 3) | 73.01 |
CCI (20) | 123.38 |
WPR (14) | -7.23 |
Momentum (10) | 5.72 |
MFI | 56.40 |
MACD Level (12, 26) | 2.21 |
Bollinger Bands | $114.80 - $127.91 |
ATR (14) | $3.54 (2.82%) |
ADX (14) | 20.88 |
OBV | 44,207,431 |
Classic Pivot Point | $123.81 |
Fibonacci Pivot Point | $123.81 |
Simple Moving Averages | $103.34 - $121.55(5 indicators) |
Exponential Moving Averages | $103.91 - $122.19(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The last trading session saw INCY close flat at 123.47, barely -0.02% different from the prior day's 123.50.
Trading Volume
Below 10d avg (1.4M)
1.1M
vs S&P 500 Today
Outperforming Market
+0.67%
52-Week Position
Upper range
82.3%
Updated: August 19, 2026 at 12:41 UTC
Quote Summary
INCY Headlines
Incyte Insider Sales, Stock Rally and New Approvals
December 23, 2025